ARG Antibiotic Resistance Gene Analysis Service

CD Genomics offers a full-service Antibiotic Resistance Gene Analysis using long-read sequencingand next generation sequencing. We detect, classify, and annotate ARGs—including those on plasmids and mobile genetic elements—backed by curated antibiotic resistance gene databases. Our workflow delivers accurate antibiotic resistance gene prediction to support CROs, academic labs, and biotech research.

Problems We Solve:

  • Hidden or low-abundance resistance genes are missed by short-read or culture-based diagnostics.
  • Difficulties in assigning ARGs to plasmids or other mobile elements—limiting insights into transmission risk.
  • Unclear classification or annotation of novel ARGs slows down research and regulatory compliance.
Sample Submission Guidelines

Antibiotic resistance gene analysis pipeline showing sample input, sequencing, ARG mapping and plasmid vs chromosome assignment

  • ARG identification & abundance profiling
  • Plasmid vs chromosome ARG localization
  • Annotation via curated antibiotic resistance gene database
  • Prediction of ARG classification & transfer potential
Table of Contents

    Introduction – Why ARG Analysis Matters

    Antibiotic resistance is recognized by the World Health Organization as one of the top 10 global health threats. Resistant infections increase mortality and treatment failures, while resistance genes persist in the environment, often hidden on plasmids and mobile elements that spread across species. Traditional diagnostic methods are slow, fragmented, and frequently fail to detect low-abundance or novel resistance genes.

    CD Genomics' sequencing-based Antibiotic Resistance Gene Analysis overcomes these barriers. By delivering full-length reads and real-time data, our service enables:

    • Comprehensive antibiotic resistance gene classification across plasmids, chromosomes, and integrative elements.
    • Precise annotation using curated antibiotic resistance gene databases.
    • Accurate antibiotic resistance gene prediction, including low-copy plasmid-borne resistance markers missed by short-read platforms.

    What We Deliver – Key Capabilities

    • Complete ARG detection: Known antibiotic resistance genes across chromosomes, plasmids, and mobile genetic elements (MGEs).
    • Accurate ARG annotation & classification using curated antibiotic resistance gene databases (e.g. CARD, ARO).
    • Plasmid vs chromosomal localization of ARGs to assess risk of horizontal gene transfer.
    • Prediction of ARG transferability and assignment to microbial hosts/taxa.
    • Abundance & diversity profiling of ARG classes in your samples.
    • Flexible design: supports real-time analysis or hybrid sequencing (Nanopore + short-reads) as required by project needs.

    Detailed Workflow

    Step Description Key Technical Steps & Tools Output & Quality Measures
    Sample QC & DNA Extraction Accepts a variety of sample types: isolates, metagenomes, environmental, clinical, agricultural. Extract high molecular weight DNA; assess purity and integrity; quantify DNA. QC metrics (yield, purity, fragment size) to ensure downstream accuracy.
    Library Prep & Sequencing Prepare samples for sequencing; supports barcoding / multiplexing if needed. Use appropriate library kits; setup flow cells; optimize for read length. Raw read datasets with high-quality long reads.
    Basecalling & Read Processing Convert raw signals to reads; filter and clean reads before downstream analysis. Use high-accuracy basecalling (e.g. Guppy), adapter trimming, low-quality/short read filtering. Cleaned FASTQs; read quality distribution; length metrics.
    Assembly & Contig Construction (Optional / Hybrid) If desired, build longer contiguous sequences to resolve complex ARG clusters. Assemblers (e.g. Flye), polishing (e.g. Racon, Medaka), hybrid polishing if short-reads are involved. Improved contig N50, more complete gene content, better structural clarity.
    ARG Detection & Database Annotation Map reads/contigs against ARG databases; classify resistance types and mechanisms. Use tools to align to CARD/ARO; cluster similar ARGs; taxonomic identification of hosts. List of ARGs with classification (gene family, mechanism), species/taxa annotation.
    Plasmid / Chromosome Assignment & MGE Detection Determine whether ARGs are located on plasmids or chromosomes; identify mobile genetic elements. Plasmid detection tools (e.g. MOB-suite or equivalents); detection of integrons, transposons, ICEs; visualization of gene clusters. Mapping of ARGs to plasmid or chromosomal context; visual gene cluster maps; transferability indicators.
    Reporting & Visualisation Generate outputs designed for research, publication, or regulatory use. Abundance tables; annotated gene maps; plots comparing ARGs across samples; phylogenetic or host contextual info. Publication-ready figures; full annotation tables; clear visualization of gene location and mobility.

    Antibiotic resistance gene analysis workflow showing sample QC, sequencing, ARG detection, plasmid mapping, and reporting

    Bioinformatics Analysis Capabilities

    Analysis Category Basic Analysis Advanced Analysis Multi-Omics Integrated Analysis
    ARG Detection & Annotation Identify known antibiotic resistance genes (ARGs) by aligning reads/contigs to curated antibiotic resistance gene databases (e.g. CARD, ARO); classify by gene family, resistance mechanism. Predict novel or low homology ARGs; analyze ARG gene clusters (co-located genes), mobile genetic elements (transposons, integrons); functional annotation of resistance mechanisms. Combine metagenomic + transcriptomic data to determine which ARGs are expressed; proteomics to verify resistance enzyme production; correlate ARG presence with phenotypic data or expression levels.
    Host / Taxonomy Mapping Assign ARGs to taxonomic levels (species, genus, family) using classification tools. Co-localization of ARGs with host microbial genomes; construct ARG-host network; infer host range and potential spread. Integrate metatranscriptome or single cell data to see active hosts; combine with 16S/shotgun for diversity; link expression / proteome to host identity.
    Plasmid vs Chromosome & Mobility Distinguish whether ARGs are plasmid-borne vs chromosomal; detection of known MGEs. Detailed mapping of plasmid structures, detection of novel plasmid fusion events; identification of insertion sequences, integrative conjugative elements; estimate plasmid copy number. Use long-read + short-read (hybrid) sequences plus transcriptomics / proteomics to confirm active mobile element usage; combine with methylation or epigenomic data to assess mobility regulation.
    Abundance & Diversity Profiling Quantify ARG abundance (normalized counts), diversity metrics (e.g. Shannon, Simpson), compare across samples. Differential abundance across conditions; co-occurrence network of ARG classes; machine learning to detect marker ARGs; trend detection. Compare metagenome vs metatranscriptome: abundance vs expression; correlate environmental/clinical metadata with ARG diversity; integrate metabolomics / environmental variables to detect selection pressures.
    Visualization & Reporting Basic visual outputs: bar plots, heat maps, ARG classification tables. ARG cluster maps, plasmid vs chromosome diagrams, host-ARG network graphs, mobile element context visualisations. Multi-omics visual dashboards: expression vs gene copy number, co-occurrence across omics, PCA/PCoA / network diagrams showing omics relationships.
    Quality Control & Confidence Filtering by read quality, minimum alignment identity and coverage; thresholding to reduce false positives; use of curated antibiotic resistance gene databases. Validation of low abundance ARGs; coverage depth support; cross-validation among reads/assemblies; assessment of gene context; use of multiple databases / models. Cross-omic validation: expression confirmation, proteomic evidence; consistency across datasets; environmental or phenotypic validation where available.

    Quality Assurance

    • Use of curated antibiotic resistance gene databases to reduce false positives.
    • Only high-confidence matches are annotated (based on sequence similarity, coverage, taxon context).
    • Verification of ARG context (gene neighbors, mobile elements) to ensure accuracy of assignments.
    • Data delivered with transparency: QC metrics, assembly statistics, read length / quality distributions.

    Applications of ARG Analysis

    Our ARG Analysis service supports a wide range of research, surveillance, and applied science applications. Below are key use cases for academic labs, CROs, and institutions.

    Clinical & Pathogen Research

    • Detect hidden or low-abundance antibiotic resistance genes, especially plasmid-mediated ARGs, in clinical isolates.
    • Predict resistance phenotypes from genomic data to support research into ARG function, strain comparison, hypothesis testing, and understanding resistance mechanisms.
    • Monitor emerging resistance (e.g. novel carbapenemases) before they spread.

    Environmental Surveillance & Public Health

    • Track ARGs in wastewater treatment plants, rivers, soil, and agricultural runoff to monitor environmental resistome dynamics.
    • Assess the mobility of ARGs via plasmids and mobile genetic elements (MGEs) to understand horizontal gene transfer risks.

    Agricultural & Veterinary Research

    • Survey resistome structures in livestock, animal microbiomes, manure, and food production systems.
    • Evaluate impacts of antibiotic use in agriculture by linkage of ARGs to plasmids or MGEs for transfer risk.

    Microbial Ecology & Fundamental Research

    • Study ARG classification and diversity across microbial communities.
    • Investigate co-occurrence of ARGs with other gene types (e.g. metal resistance genes), to understand co-selection pressures.
    • Resolve full gene context and genetic background (chromosome vs plasmid, neighboring elements) that short reads cannot adequately capture.

    Real-Time & Field-Deployable Monitoring

    • Point-of-care or in situ environments (clinics, field sites) benefit from real-time ARG detection workflows.
    • Early warning systems for outbreak tracking, environmental contamination events, and emerging resistance threats.

    Deliverables

    • Raw and processed read files (FASTQ / FASTA)
    • Assembled contigs or plasmid sequences if requested
    • Annotated ARG tables: gene names, class, mechanism, associated antibiotic(s)
    • Plasmid vs chromosome assignment reports
    • Abundance and diversity profiles of ARGs per sample
    • Visualizations: gene maps, cluster diagrams, host/phylogeny context
    • Full methods documentation & QC report to ensure reproducibility
    Absolute metagenomic sequencing results with KEGG pathway, TCDB transporter classification, and PCA analysis

    Frequently Asked Questions

    Q: What is an Antibiotic Resistance Gene Analysis service and how can it help my research?

    Antibiotic Resistance Gene Analysis is a service that uses sequencing (e.g. Nanopore long reads) and bioinformatics to detect, classify, and annotate antibiotic resistance genes (ARGs) in your samples; it helps labs, CRO clients, and academic institutions to discover ARG types (plasmid-borne or chromosomal), predict resistance mechanisms, track mobile genetic elements, and quantify ARG abundance to support surveillance, diagnostics, or agricultural/environmental studies.

    Q: How accurate is ARG classification and annotation using curated resistance gene databases?

    When using curated antibiotic resistance gene databases (like CARD/ARO/SARG), combined with high-quality long reads (e.g. from Nanopore), the annotation and classification of ARGs are very accurate; matching thresholds (identity, coverage) ensure genes are correctly assigned, and plasmid vs chromosome assignment gives context for mobile ARGs, reducing misclassification and helping in resistance prediction.

    Q: Can you distinguish ARGs on plasmids from those on chromosomes, and why does this matter?

    Yes, part of the analysis workflow involves plasmid vs chromosome assignment by detecting plasmid sequences and mobile genetic elements (MGEs), so we can tell if an ARG is likely transferable; this distinction matters because plasmid-borne ARGs spread more readily between bacteria, increasing risk, and knowing the location improves understanding of gene mobility and epidemiology.

    Q: Do I need a higher volume or special quality of DNA for ARG detection?

    To achieve reliable detection, especially for low-abundance ARGs or plasmid localization, high molecular weight DNA with good purity is preferred; though we can work with a range of sample types, quality filtering and library prep steps are optimized to reduce noise and improve confidence in antibiotic resistance gene prediction.

    Q: How do you ensure low false positives in ARG detection and prediction?

    We use stringent bioinformatics pipelines including basecalling quality control, read trimming, alignment to curated antibiotic resistance gene databases, filtering by sequence identity and coverage thresholds, and verification of gene context (neighboring mobile elements or chromosome/plasmid assignment) so that predictions of antibiotic resistance genes are robust and reliable.

    Q: Can this service be used for both clinical samples and environmental or agricultural samples?

    Yes, this ARG analysis is applicable to a variety of sample types—clinical isolates, wastewater, soil, livestock microbiomes, etc.—since the methods detect ARGs across diverse microbial communities; the same classification, annotation, and plasmid assignment capabilities apply, though sample preparation and depth may vary depending on environment or matrix type.

    Q: What kind of outputs and reports will I receive from the ARG analysis service?

    You will receive annotated tables of ARGs (gene name, mechanism/class, host taxa), abundance and diversity profiling, plasmid vs chromosome localization maps, visualizations (heat maps, gene cluster diagrams, network plots), raw and processed sequence files, and methods/QC documentation for reproducibility.

    Q: What related sequencing services can complement the ARG Analysis?

    Services like Nanopore Ultra-Long Sequencing, Nanopore Amplicon Sequencing, Nanopore Target Sequencing, Nanopore Full-Length lncRNA Sequencing, Nanopore Full-Length Transcript Sequencing, Nanopore Direct RNA Sequencing, and the general Nanopore Sequencing Overview are all complementary offerings that can enhance ARG detection (for example, ultra-long reads help resolve large plasmids, amplicon or targeted approaches help validate specific genes) enhancing the overall understanding of antibiotic resistance gene plasmid location, classification, and annotation.

    Case Study: Resistome and Gut Microbiome in Hospitalized Patients, Southern Brazil

    Source: Frontiers in Antibiotics (2025)
    DOI: 10.3389/frabi.2024.1489356

    1. Background

    Antimicrobial resistance is a critical global health challenge. Hospitalized patients are particularly vulnerable due to antibiotic exposure and altered microbiomes. This study investigated the gut resistome and microbiome composition of patients admitted to a hospital in southern Brazil, a region with intensive livestock activity that increases environmental ARG exposure.

    2. Methods

    • Sample collection: Fecal samples from patients at admission and discharge.
    • Sequencing: Metagenomic sequencing of microbial DNA.
    • Bioinformatics: ARG detection against curated antibiotic resistance gene databases, resistome quantification, and microbiome taxonomic profiling.
    • Comparisons: Admission vs. discharge profiles to identify resistome dynamics during hospitalization.

    3. Results

    • High prevalence of aminoglycoside and tetracycline resistance genes in patient microbiomes.
    • mcr genes (conferring colistin resistance) were detected both at admission and discharge.
    • Resistome diversity increased during hospitalization, with some ARGs enriched after antibiotic treatment.
    • Changes in microbiome composition (e.g., increased Enterobacteriaceae) were associated with resistome shifts.

    Gut resistome analysis showing aminoglycoside, tetracycline, and mcr antibiotic resistance genes in hospitalized patients at admission and dischargeFigure. Resistome composition in hospitalized patients, comparing admission and discharge samples. Aminoglycoside, tetracycline, and mcr gene classes are highlighted as dominant contributors.

    4. Conclusions

    • Hospitalization and antibiotic exposure can expand the gut resistome, enriching clinically important ARGs.
    • The persistence of mcr genes raises concerns about transferable colistin resistance.
    • Integrated microbiome and resistome analysis provides actionable insights for antibiotic stewardship and infection control.
    • This case demonstrates the value of ARG surveillance using metagenomics in clinical settings.

    References:

    1. Coltro EP, Cafferati Beltrame L, da Cunha CR, Zamparette CP, Feltrin C, Benetti Filho V, Vanny PA, Beduschi Filho S, Klein TCR, Scheffer MC, Palmeiro JK, Wagner G, Sincero TCM, Zárate-Bladés CR. Evaluation of the resistome and gut microbiome composition of hospitalized patients in a health unit of southern Brazil coming from a high animal husbandry production region. Front Antibiot. 2025 Jan 17;3:1489356. doi: 10.3389/frabi.2024.1489356. PMID: 39896720; PMCID: PMC11782142.
    2. Peter S, Bosio M, Gross C, Bezdan D, Gutierrez J, Oberhettinger P, Liese J, Vogel W, Dörfel D, Berger L, Marschal M, Willmann M, Gut I, Gut M, Autenrieth I, Ossowski S. Tracking of Antibiotic Resistance Transfer and Rapid Plasmid Evolution in a Hospital Setting by Nanopore Sequencing. mSphere. 2020 Aug 19;5(4):e00525-20. doi: 10.1128/mSphere.00525-20. PMID: 32817379; PMCID: PMC7440845.
    3. Arango-Argoty, G.A., Dai, D., Pruden, A. et al. NanoARG: a web service for detecting and contextualizing antimicrobial resistance genes from nanopore-derived metagenomes. Microbiome 7, 88 (2019).
    For research purposes only, not intended for clinical diagnosis, treatment, or individual health assessments.
    Related Services
    Quote Request
    ! For research purposes only, not intended for clinical diagnosis, treatment, or individual health assessments.
    Contact CD Genomics
    Terms & Conditions | Privacy Policy | Feedback   Copyright © CD Genomics. All rights reserved.
    Top